Investigating a clinically actionable mutation for monitoring low-grade serous ovarian cancer: A case report.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Silva, RMoran, B
Das, S
Mulligan, N
Doughty, M
Treacy, A
Sheahan, K
Kelly, C M
Duffy, A G
Perry, A S
Brennan, D J
Issue Date
2022-02-06Keywords
Cell-free circulating DNADigital droplet PCR
Low-grade serous ovarian cancer
Next-generation sequencing
targeted therapy
Metadata
Show full item recordJournal
Case reports in women's healthDOI
10.1016/j.crwh.2022.e00395PubMed ID
35198414Item Type
ArticleLanguage
enEISSN
2214-9112ae974a485f413a2113503eed53cd6c53
10.1016/j.crwh.2022.e00395
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as © 2022 The Authors. Published by Elsevier B.V.
Related articles
- Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
- Authors: Shrestha R, Llaurado Fernandez M, Dawson A, Hoenisch J, Volik S, Lin YY, Anderson S, Kim H, Haegert AM, Colborne S, Wong NKY, McConeghy B, Bell RH, Brahmbhatt S, Lee CH, DiMattia GE, Le Bihan S, Morin GB, Collins CC, Carey MS
- Issue date: 2021 Apr 1
- KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.
- Authors: Tsang YT, Deavers MT, Sun CC, Kwan SY, Kuo E, Malpica A, Mok SC, Gershenson DM, Wong KK
- Issue date: 2013 Dec
- Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
- Authors: Bustamante Alvarez JG, Janse S, Owen DH, Kiourtsis S, Bertino EM, He K, Carbone DP, Otterson GA
- Issue date: 2021 Jul
- Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
- Authors: Tzanikou E, Haselmann V, Markou A, Duda A, Utikal J, Neumaier M, Lianidou ES
- Issue date: 2020 Oct 25
- Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma.
- Authors: Rushton T, Krause HB, Samec T, Elliott A, Karnezis AN, Toboni MD, Thaker PH, Braxton DR, Oberley M, Gershenson DM, Armstrong DK
- Issue date: 2024 Dec